论文部分内容阅读
资料报道产程中应用催产素可引起新生儿高胆红素血症,作者为此进行了研究。作者观察了1393例孕37周以上阴道分娩之新生儿,将其分三组:(1)自然临产;(2)用催产素加速分娩;(3)人工破膜后催产素静脉点滴。新生儿出生24小时内均肌注维生素K_1 1毫克。出生后第3、6天,测定血胆红素含量,超过12毫克/100毫升者考虑为高胆红素血症,有475例因早期出院仅测定一次。检验结果:1395例中有40例婴儿因体重过低或有红细胞抗体(溶血症)而未统计在内。仅余1353
Data reported that oxytocin in the labor process can cause neonatal hyperbilirubinemia, the authors conducted a study. The authors looked at 1,393 newborns with vaginal deliveries of more than 37 weeks of gestation, divided into three groups: (1) spontaneous labor; (2) oxytocin to accelerate delivery; and (3) oxytocin intravenous drip after artificial rupture of membranes. Newborns were intramuscularly injected vitamin K_1 1 mg within 24 hours of birth. On the 3rd and 6th day after birth, the blood bilirubin level was measured and over 12 mg / 100 ml was considered as hyperbilirubinemia, and 475 cases were only tested once due to early discharge. Test results: 1395 cases, 40 infants were under-weight due to underweight or red blood cell antibodies (hemolytic disease) and not included. Only 1353 left